R&D News | pharmaphorum

News

Shares in Vertex Pharma have come under pressure after one of its non-opioid pain candidates failed to move the needle in a mid-stage trial.

News

The Gates Foundation is ramping up support for women's health research, pumping $2.5bn into new projects in this 'ignored, underfunded' area of R&D.

News

The first phase 3 readout with Spine BioPharma's drug candidate for chronic low back pain has proved disappointing.

News

ChatGPT can't replace humans when it comes to checking patient eligibility to take part in clinical trials, but it can save time and money.

News

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

AbbVie could be heading for its second acquisition in the space of a month, as rumours emerge of a $1bn bid for psychiatric drug developer Gilgamesh.